In several models of triple negative breast cancer (4T1 and 67NR), CR has been shown to have an additive effect to decrease the primary tumor growth when combined with radiation and was noted to inhibit the IGF-1R/Akt pathway [77]. The gene discussed is IGF1R; the disease is neoplasm.